Innovating Works

filtrando por convocatoria: HORIZON-MISS-2023-CANCER-01-02

GLIOMATCH: The malignant Glioma immuno-oncology matchmaker: towards data-driven precision medicine using spatia... KATHOLIEKE UNIVERSITEIT LEUVEN tramitó un HORIZON EUROPE: HORIZON-MISS-2023-CANCER-01 "Adult and paediatric malignant glioma (GBM and pHGG) remain among the most difficult-to-treat cancers with 5-year survival rates of <5% des...
2023-12-07 - 2028-12-31 | Financiado
ENDEAVOR: Endoscopic brush cytology and single cell clinal dynamics of early easophageal adenocarcinoma for de... UNIVERSITEIT ANTWERPEN tramitó un HORIZON EUROPE: HORIZON-MISS-2023-CANCER-01 In many European countries the recent rise in incidence of esophageal adenocarcinoma (EAC) is without precedent. EAC is notorious for its h...
2023-12-11 - 2028-12-31 | Financiado
MULTIR: MULti-Tumour based prediction and manipulation of Immune Response INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE tramitó un HORIZON EUROPE: HORIZON-MISS-2023-CANCER-01 Only few patients respond to tumor treatment as desired. Treatment heavily relies on host tumor interactions, including exploiting the host...
2024-01-01 - 2027-12-31 | Financiado
MONALISA: A SIOPEN pragmatic clinical trial to MOnitor NeuroblastomA relapse with LIquid biopsy Sensitive Anal... SIOP EUROPE tramitó un HORIZON EUROPE: HORIZON-MISS-2023-CANCER-01 High-risk neuroblastoma accounts for 15% of cancer related-deaths in children. Half of the >1500 patients yearly diagnosed with neuroblastom...
2024-01-01 - 2028-12-31 | Financiado
RESOLVE: Residual disease assessment in hematologic malignancies to improve patient-relevant outcomes across... MEDIZINISCHE HOCHSCHULE HANNOVER tramitó un HORIZON EUROPE: HORIZON-MISS-2023-CANCER-01 "MeMeasurable residual disease (MRD) detected by multiparameter flow cytometry (MFC) has strong prognostic value in patients with the most f...
2024-04-01 - 2029-03-31 | Financiado
iBeCHANGE: IBeCHANGE - ADDRESSING PSYCHOSOCIAL AND LIFESTYLE RISK FACTORS TO PROMOTE PRIMARY CANCER PREVENTION:... ISTITUTO EUROPEO DI ONCOLOGIA SRL tramitó un HORIZON EUROPE: HORIZON-MISS-2023-CANCER-01 "Europe’s Beating Cancer Plan set has ambitious goals addressing key behavioral risk factors for cancer development, such as tobacco (target...
2023-12-01 - 2028-11-30 | Financiado
PREMIO COLLAB: Personalised response monitoring in oncology: co-creating clinical trials in advanced breast cancer REGION SYDDANMARK tramitó un HORIZON EUROPE: HORIZON-MISS-2023-CANCER-01 PREMIO COLLAB’s vision is to prolong overall survival and improve the quality of life for patients with metastatic breast cancer (MBC) by pr...
2024-01-01 - 2029-12-31 | Financiado
Arturo: Assessing the role of intratumoral microbiota in therapy responses using patient-derived tumor-on-ch... INSTITUT CURIE tramitó un HORIZON EUROPE: HORIZON-MISS-2023-CANCER-01 "This action is part of the Cancer Mission cluster of projects on “Understanding (tumour-host interactions)"".Challenge: Primary or acquired...
2024-07-01 - 2028-06-30 | Financiado
SPACETIME: SPatial Analysis of Cancer Evolution in the Tumour Immune MicroEnvironment STICHTING AMSTERDAM UMC tramitó un HORIZON EUROPE: HORIZON-MISS-2023-CANCER-01 The introduction of immune checkpoint therapy for Non-Small Cell Lung Cancer (NSCLC) has improved clinical outcomes. However, due to primary...
2024-08-01 - 2029-07-31 | Financiado
HIT-GLIO: Targeting tumour-host interactions in paediatric malignant gliomas to reinvigorate immunity and impr... INSTYTUT BIOLOGII DOSWIADCZALNEJ IM. M. NENCKIEGO POLSKIEJ AKADEMII NAUK tramitó un HORIZON EUROPE: HORIZON-MISS-2023-CANCER-01 Paediatric high-grade gliomas (pHGGs) are malignant, deadly tumours developing in infants and children. Mutations in histone coding genes di...
2023-12-01 - 2027-11-30 | Financiado
SUNRISE: SUstaiNable inteRventions and healthy behavIours for adoleScent primary prEvention of cancer with di... ETHNIKO KENTRO EREVNAS KAI TECHNOLOGIKIS ANAPTYXIS tramitó un HORIZON EUROPE: HORIZON-MISS-2023-CANCER-01 Primary prevention of cancer through behaviour changes in adolescence – a critical period in which many risk behaviours are initiated –, is...
2024-01-01 - 2028-04-30 | Financiado